RETROVIR, a drug licensed in Britain for treating people with AIDS or
other symptoms of infection with HIV, may soon be available for treating
people with HIV who have shown no sign of illness. The Wellcome Foundation,
the British pharmaceuticals company, announced this week that it had won
provisional clearance from the Committee for Proprietary Medicinal Products
of the European Commission to seek wider use for Retrovir. Individual member
states of the EC are now considering the committee’s recommendations.
More from Â鶹´«Ã½
Explore the latest news, articles and features
Popular articles
Trending Â鶹´«Ã½ articles
1
Are Neanderthals descendants of modern humans?
2
Why is it so hard to change your mind?
3
The biggest threat to Chernobyl is no longer radiation
4
Our dreams become more emotive and symbolic as we approach death
5
Electric vehicle owners could earn thousands by supporting power grid
6
Surprising male G-spot found in most detailed study of the penis yet
7
From autism to migraines, birth order may have wide-reaching effects
8
Collapse of key ocean current may release billions of tonnes of carbon
9
How worried should you be about an AI apocalypse?
10
The man who crawls into the perilous heart of the Chernobyl reactor
